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This qualitative bounded case study focuses on how the
therapist integrates the quality of life into his or her
treatment plan when treating a bipolar patient. Quality of
life may be defined as an individual’s perception of his or
her position in life in relation to psychological and physical
health, social relationships, goals, expectations, and
environment (WHO, 1995). This study specifically explored how
therapists treat their bipolar patients and how they integrate
QoL into therapy. Two men and seven women were interviewed in
Santa Barbara, California. The criterion for participants
included licensed psychologists who have treated at least one
bipolar patient in the past. Participants were recruited from
local agencies as well as through connections through fellow
mental health professionals, university professors and
colleagues. Using a case study analysis, an integration of
quality of life was interpreted to observe common themes. The
electronic version of the Dissertation is accessible in the
open-access Ohiolink ETD Center. http://etd.ohiolink.edu./
iii
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Bipolar disorder (BD) is a debilitating, lifelong
affective disorder affecting the population worldwide. As the
sixth most common cause of disability in the United States, it
is a nationwide crisis (Leahy, 2007). A disorder with
consequences involving mental and physical health, intimate
and social relationships, and the productivity of the bipolar
individual’s life, it undoubtedly manifests in a toll on the
diagnosed individual’s quality of life. For the sake of this
research, BD will only refer to bipolar I disorder.
It has been noted that while an individual may recover
clinically after an episode, he or she may not have recovered
functionally (Miklowitz, 2008), creating an upward and
sometimes unattainable battle to return to pre-episode
routines and lifestyle. While the symptom reduction of a
bipolar patient hospitalized for severity of symptoms may
permit discharge, the patient may now be faced with returning
to a life outside the hospital that has been damaged by the
manic or hypomanic event. For example, the patient may have
caused damage to important relationships, have created new or
exacerbated existing financial or legal troubles, or even have
consequential health ramifications such as the acquisition of
a sexual transmitted infection or disease.
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It has been shown that elevated depressive symptoms have
led to actions by patients that have exacerbated the course of
the disorder (Rowe & Morris, 2012). Depressive symptoms have,
in fact, been a predictor for rehospitalization (Carlson et
al., 2012; Lin, Kuo, Liu, Huang, & Chen, 2009). While the
patient may appear to have recovered clinically from the
episode, the residual effects of the disorder may have future
ramifications toward functional recovery, and the success rate
after leaving the hospital and attaining a pre-episode routine
and lifestyle are impacted, possibly inducing or exacerbating
depression.
In a 2009 study analyzing the factors affecting time to
re-hospitalization for Chinese patients with bipolar I
disorder, 57.8% were readmitted due to depressive episodes,
compared to 20% who had been readmitted due to bipolar mania
during one year follow up discharge (Lin et al., 2009). It was
hypothesized by the authors that depressive episodes are more
likely to re-occur than manic episodes.
Additionally, there is variability in the manifestation
of the disorder itself, the patient’s range of functionality,
as well as the patient’s picture of recovery. Some patients
function well in the context of severe symptoms, while others
report significant quality of life decrements in the context
of relatively few symptoms (Murry & Michalak, 2012).
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Quality of life (QoL) is an individual’s perception of
his or her position in life in relation to psychological and
physical health, social relationships, goals, expectations,
and environment (WHO, 1995). Studies show that QoL is
significantly reduced for those diagnosed with BD compared to
those diagnosed with other psychiatric disorders, as evidenced
by recurrence of episodes, mortality, comorbidity, distress in
interpersonal relationships, impaired cognitive functioning,
and difficulty in many other critical aspects of life (Leahy,
2007; McNamara, Nandagopal, Strakowski, DelBellow, 2010;
Perlis, 2009; Michalak, Murray, Young, & Lam, 2008;
Baldassano, 2006; Suominenet al., 2007; Rizvi & Zaretsky,
2007).
A full and complete clinical picture of recovery should
include a return to an acceptable and realistic quality of
life for the individual patient. While traditional recovery
outcomes in BD have solely been determined by objective
measures based on the pathology of the patient, such as
recurrence of episodes, response to medication, or degree of
symptom remission on clinician-rated assessment scales
(Michalak, Murray, & CREST.BD, 2010), there has been
increasing emphasis on the importance of additional, patient
centered forms of assessment to measure treatment outcome and
recovery, such as QoL of the bipolar individual.
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Affecting 5.7 million adult Americans in a given year,
Bipolar Disorder (BD) continues to be a nationwide concern
(National Institute of Mental Health [NIMH], n.d.). A lifelong
disorder impacting the patient’s mental, physical, social and
emotional state, BD remains a significant and critical
concern.
Recent studies showed that there is a concern regarding
the predictors of recovery from a manic or hypomanic episode,
or success after treatment. Specifically, it has been found
that patients who were considered “recovered” were readmitted
for hospitalization (Carlson et al., 2012; Lin, Kuo, Liu,
Huang, & Chen, 2009, Lin et al., 2009; Lin, C., Chen, M.,
Chou, L., Lin, C., Chen, C., & Lane, H., 2010).  “Reports also
indicate that 1-year rehospitalization rates of bipolar I
disorder range from 41% to 60%” (Lin, C., Chen, M., Chou, L.,
Lin, C., Chen, C., & Lane, H., 2010). The recovery that was
presumed after the patient was declared ready for discharge,
was not constant. It can therefore be deduced that while there
is a reduction in the severity of symptoms, there is also a
difficulty for the majority of patients to return to their
pre-episode routine and lifestyle.
In addition, existing works have shown that the quality
of life has not been utilized or effectively integrated by
treating clinicians (Baldassano, 2006; Leahy, 2007; McNamara
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et al., 2010; Michalak et al., 2008; Perlis, 2009; Rizvi &
Zaretsky, 2007; Suominenet al., 2007;). This qualitative case
study will attempt to answer questions regarding the
therapist’s integration and utilization of QoL into the
treatment plan for bipolar patients. By examining the
therapist’s view of his or her individual implementation and
utilization of QoL into the treatment of bipolar patients,
this current work will contribute to the further exploration
of viable treatment of BD.
With the rate of bipolar patients completed suicide at 60
times higher than the general population (Leahy, 2007), the
highest association with comorbid substance use disorders
(McNamara et al., 2010), and rates of episode relapse
resulting in 47% of the patient’s life being spent in a
symptomatic state (Miklowitz, 2008), it is of great concern
both to the clinical world as well as our public health, to
contribute to the growing research on those suffering with BD.
Quality of Life is a component that can help in the
development of a clear clinical picture of the current status
of the bipolar patient, help guide the individualized
treatment plan, and serve as an indicator of whether or not
the treatment is working after implementation. Perhaps it can
even enhance the doctor-patient relationship. While a patient
may fit criteria for recovery from a manic or depressive
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episode, they still may not be functioning at a level that
will allow them to cope with the collateral damage caused by
the episode or navigate through the necessary steps to prevent
episode recurrence (refilling prescriptions, setting up doctor
appointments, etc.), which may lead to, exacerbate, or hasten
a depressive episode. With research showing depressive
symptoms and episodes as the most debilitating aspect of BD,
there must be a marriage between the traditional methods of
clinical symptom reduction and the nontraditional
incorporation of QoL in order to prevent rehospitalization,
lessen the recurrence of episodes, and enhance the mental
health of the patient.
It is the aim of this study to explore the factors
guiding psychologists who treat bipolar patients in their
decision of how to integrate QoL into their treatment plans in
order to prevent the rehospitalization of their patients. To
date, clinicians generally look to traditional methods to
assess recovery in a patient, however research is showing that
bipolar patients are not doing well regardless of improvement
on traditional outcome measures such as rates of relapse,
hospitalization, or symptom reduction (Carlson et al., 2012;
Lin, Kuo, Liu, Huang, & Chen, 2009, Lin et al., 2009; Lin et
al., 2010; Michalak, Murray, & CREST.BD, 2010; Miklowitz,
2008). A working model of “health” or “functionality” exists
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for the psychologist to measure progress by determining
whether symptoms are under control. However, the question
remains of whether the psychologist’s methods are actually
improving the quality of his or her patient’s life.
There has been increased attention to the QoL in
depressive disorders, however it has been comparatively slow
in BD, in part due to the reservations about the ability of
bipolar patients to reliably complete self-report measures
when manic (Michalak, Yatham, & Lam, 2005). Gathering data on
the factors behind the clinical decisions of psychologists on
the integration of QoL into the treatment of bipolar patients
may shed light on the success rate of both the therapy as well
as the therapeutic relationship. As the QoL in those
struggling with BD has been shown to be greatly impaired,
investigating ways to integrate it into the clinical picture
of recovery will be an important step in the efficacy of
bipolar treatment. It will also add to the growing literature




The primary purpose of this research is to investigate
clinical psychologists’ integration of the quality of life
(QoL) construct into their treatment of bipolar I patients. In
an effort to capture and relate both the essence of bipolar
disorder and the concept of QoL, an extensive review of the
literature has been completed in both areas.
An intricate and powerful diagnosis, BD has many
identifying features and themes. One powerful theme that arose
during the review of the literature is the age of onset of the
disorder. This not only articulates the course of the
disorder, but also underscores the debilitating effects it may
have on the afflicted person’s development. Continuing with
the theme of illustrating the disorder, as well as the impact
it has on those diagnosed, this literature review presents
information regarding the potential comorbid illnesses, as
well as contributing factors to diagnosis.
Currently, the use of medication is the cardinal form of
treatment for those experiencing manic/hypomanic and mixed
episodes, regardless of the rate of success and the patient’s
concerns and apprehensions (Miklowitz, 2008; Sajatovic,
Jenkins, Cassidy, & Muzina, 2009). The QoL construct
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highlights the importance of the whole picture of the
patient’s wellbeing.
Bipolar Disorder
Bipolar Disorder (BD) is a complex, chronic psychiatric
condition characterized by the profound effect it has on the
individual’s moods, experiences of emotion, and affect. True
to its moniker, the mood swings in BD are often described as
swinging between two poles, with recurring episodes of
depression and mania, a period of abnormally elevated,
expansive, or irritable mood, and increased energy/activity or
hypomania, a subsyndromal counterpart to mania. While BD is
usually defined by manic or hypomanic episodes, recent studies
show that not only do depressive symptoms predominate over
manic symptoms in the majority of patients, but bipolar
depression also accounts for much of the comorbidity and
mortality associated with the disorder and its significant
impact on the quality of central areas in the bipolar
individual’s life (Michalak et al., 2008).
Between 3 to 5% of the American population is diagnosed
with BD at any given time (Leahy, 2007; Rizvi & Zaretsky,
2007), affecting one in every 50 people, or as many as one-in-
25 people according to some estimates (Miklowitz, 2011). BD is
the sixth most common cause of disability in the United
States; globally, it is the fifth leading cause of disability
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among 15-44 year olds, as well as the ninth leading cause of
years lost to death or disability (Leahy, 2007; Steinkuller &
Rheineck, 2009). Those who suffer with this debilitating
disorder are at a high lifetime risk for problems in varied
critical domains of life, from impairment in family and social
relationships, to a substantial impact on physical health and
economic security (Steinkuller & Rheineck, 2009). It is
estimated that between 25% and 60% of individuals with BD will
attempt suicide at least once in their lives and between 4%
and 19% will be successful (Novick, Swartz, & Frank, 2010).
Compared to the general population, bipolar individuals’
lifetime rates for completed suicide are 60 times higher, with
a higher rate of success for each attempt (Leahy, 2007).
Treating clinicians will find themselves faced with a
challenging amalgam requiring skill and competency in many
areas including, but not limited to, the identification of the
stages inherent in the expression of bipolar disorders (mania,
hypomania, mixed states, and depression), pharmacological
treatments, dual diagnosis, personality and anxiety disorders,
suicidality, and environmental stressors.
A survey by the National Depressive and Manic-Depressive
Association found that 60% of patients with BD had previously
received a misdiagnosis of unipolar depression, and 26% had
been previously misdiagnosed with anxiety disorder
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(Hirschfeld, Lewis, &Vormik, 2003). Other common misdiagnoses
in the survey included schizophrenia (18%), borderline or
antisocial personality disorder (17%), alcohol abuse or
dependence (14%), and schizoaffective disorder (11%).
Receiving an incorrect diagnosis can lead to an insufficient,
ineffective or harmful treatment plan that will not only
prolong the suffering of the bipolar individual, but may also
deter them from seeking help in the future (Hirschfeld et al.,
2003).
Age at Onset
Perlis, Dennehy, Nierenberg, Sachs, et al. (2009)
examined prospective outcomes during up to two years of
naturalistic treatment among 3,658 adult bipolar I and bipolar
II outpatients participating in the Systematic Treatment
Enhancement Program for Bipolar Disorder (STEP-BD). Consistent
with previous reports in smaller cohorts, adults with
retrospectively reported early-onset bipolar disorder appear
to be at greater risk for recurrence, chronicity of mood
symptoms, and functional impairment during prospective
observation (Perlis, 2009). Many bipolar individuals do not
seek treatment until adulthood, resulting in the majority of
age at onset studies relying heavily upon retroactive patient
self-report. Given this observation, the integration of the
QoL in the treatment of bipolar disorders will positively
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effect the treatment itself when the integration happens at
age at onset. While little is known about the course of
childhood and adolescent onset BD, these individuals have
shown an increased risk for greater life impairment including
higher rates of psychotic symptoms, greater comorbidity, and
suicidality (McNamara et al., 2010; Perlis, 2009; Baldassano,
2006; Suominen et al., 2007).
Suominen et al. (2007) interviewed 191 bipolar I and
bipolar II patients to gather information regarding age at
onset of mood symptoms, clinical course, treatment,
comorbidity, and functional status. Consistent with previous
studies, an early age at onset was related to more psychotic
symptoms, rapid cycling, comorbidity, and suicidal ideation.
Subjects with earlier onset had more lifetime depressive,
manic, and mixed phases. Additionally, age at first
hospitalization was lower for early onset subjects compared to
adult onset subjects.
Between 15 and 18% of patients suffering from BD have
their initial onset before the age of 13 years old, while 50
and 66% experience initial onset before the age of 19 years
(Morris, Miklowitz, & Waxmonsky, 2007). These statistics show
that age at onset occurs at a particularly critical
developmental stage of physical self-sustenance and
psychological autonomy, potentially setting the stage for
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longstanding damage along the maturational path. A child
experiencing symptoms of BD may develop a sense of self
characterized by who they are during an episode and between
episodes, which may be few and far between due to lack of
psychological intervention. The potential consequences this
may have on the children’s ability to flourish later in life
can be great, affecting their perception of what they are
capable and deserving of in all areas of their life. Future
relationships may be marred by low self-esteem, goals never
met, and a QoL below what individuals feel they want but have
perhaps resigned to never attaining. Further research is
needed to investigate and substantiate this impact.
Comorbidity
The Systematic Treatment Enhancement Program for Bipolar
Disorder (STEP-BD) was funded as part of a National Institute
of Mental Health initiative to develop effectiveness
information about treatments, illness course, and assessment
strategies (Bowden et al., 2011). Enrolling 4,361 participants
from 1999 to 2005, the STEP-BD studies were intended to be
generalizable to both the research knowledge base for BD and
to clinical care of bipolar patients (Bowden et al., 2011).
The largest federally funded treatment study to date, along
with the provision of extensive knowledge about the treatment
of BD, the STEP-BD served as the foundation for many other
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studies to expand the pool of knowledge of BD in other areas
of research.
Part of the heterogeneous composite of bipolar
individuals is the high prevalence of comorbid conditions.
Comorbid conditions have been affiliated with complications
and poorer outcomes, such as an earlier age of onset, shorter
periods of euthymia, and an increase in suicidality and
violence (Baldassano, 2006; Rizvi & Zaretsky, 2007). According
to data from the STEP-BD, conditions that commonly co-occur
with BD are anxiety disorders, attention-deficit/hyperactivity
disorder, and substance and alcohol abuse disorder (Nierenberg
et al., 2005).
Data from the first 500 participants in the STEP-BD study
demonstrated the elevated rate of anxiety disorders in bipolar
individuals, revealing that approximately half had experienced
some type of anxiety disorder (Simon et al., 2004). When
comparing bipolar individuals who had an anxiety disorder with
those who did not, STEP-BD data illustrated the comorbid
diagnosis increased the risk of suicide attempts. Among
patients with any current anxiety disorders, 60.3% of patients
had a history of suicide attempts, versus 27.4% of patients
without current anxiety disorders (Simon et al., 2004).
Additionally, the STEP-BD data showed the average age of onset
for bipolar patients without any lifetime anxiety disorder was
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19.4 years, opposed to an age of onset of 15.6 for those
patients with any lifetime anxiety disorder (Simon et al.,
2004; Baldassano, 2006).
Bipolar disorder has been reported as having the highest
association with substance use disorder of any DSM-IV Axis I
psychiatric disorder (McNamara et al., 2010). Compared with
seven other mental disorders, data from the STEP-BD revealed
that bipolar I and bipolar II disorders came only second to
antisocial personality disorder in rate of alcohol abuse and
dependence (Baldassano, 2006). While 16.5% of patients with
major depression had received diagnoses of alcohol abuse or
dependence, the rate of alcohol abuse and dependence was 46.2%
in patients with bipolar I disorder and 39.2% for bipolar II
(Baldassano, 2006).
Contributing Factors
While the cause of BD is currently unknown, genetic
factors that may influence the development of the disorder are
continually being identified and studies that integrate
genetics and neuroimaging methods are increasingly being
performed (Espie et al., 2012; McNarmara et al., 2010).
Familial high-risk research has demonstrated high rates of
affective disorders, particularly BD, in the adolescent
offspring of bipolar parents (Espie et al., 2012), with the
possession of first-degree bipolar relatives substantially
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increasing the risk for developing BD. Approximately 55% of
the offspring of bipolar parents have a mental health
disorder, 30% of which is a mood disorder (McNarmara et al.,
2010). Additionally, offspring of bipolar parents have an
increased risk of developing early-onset BD. As BD does not
only impact the individual, but also the environment in which
they live, the poor functioning of a mentally ill parent may
impact the illness course of offspring. The offspring must
deal with all aspects of the affected parent’s disorder,
including any impact on the family’s social life and economic
wellbeing. This means that the environment where patients with
bipolar disorder live also affects the disorder itself. This
environment, as mentioned above, is not limited to the
physical environment. It can actually be the psychological
construct by which patients are bound to live. This
exemplifies the importance of the integration of QoL into the
treatment plan for patients with bipolar disorder as the
disorder potentially infiltrates all areas of life.
There is considerable evidence that stressful life
events, support systems, as well as the ability to regulate
affect with coping skills contribute to the expression of the
disorder (Leahy, 2007). A stressful life event may serve as
both the catalyst for a depressive or manic episode, as well
as the consequence of one (Leahy, 2007). It has been
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hypothesized that stressful life events and psychosocial
stressors in and of themselves, such as severe trauma or abuse
during childhood, have been associated with an increased risk
for developing BD independent of familial risk (Steinkuller &
Rheineck, 2009). Family attitudes and behaviors have been
shown to shape the course of serious mental illness, with
bipolar individuals who have strong support systems, such as a
healthy and sober spouse who is willing to go to couple’s
therapy, or relatives that help with errands after
hospitalization, faring better (Steinkuller & Rheineck, 2009;
Rowe & Morris, 2012). Evidence shows that patients whose
parents or spouses express high levels of criticism,
hostility, or emotional over-involvement during or immediately
after an acute episode are more likely to relapse or have
continued severe symptoms in the year following the episode
(Steinkuller & Rheineck, 2009). Research shows that partners
of individuals with BD are at risk for higher rates of
depression compared to partners of people without BD, and when
close others have elevated depressive symptoms, they are more
likely to behave in maladaptive ways that exacerbate the
course of BD (Rowe & Morris, 2012).
Over time, as bipolar research utilizes the integration
of genetics and neuroimaging methods, genetic factors that may
influence the development of the disorder are being
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identified. Despite many challenges facing the field of
neuroimaging researching BD (such as clinical heterogeneity,
medication regimes), there is remarkable convergence among
findings supporting the view of BD as a neurodevelopmental
disorder. An amygdala-anterioparalimbic neural system appears
to serve a chief function in BD. Findings in the amygdala and
in the ventral prefrontal cortex, as well as in their
connections, have been particularly consistent results, with
abnormalities reported across mood states of the disorder and
in studies employing many different experimental paradigms
suggesting that dysfunction in these regions is a trait
feature of the disorder (Blond, Fredericks, & Blumberg, 2012).
Abnormalities in subcortical components of the amygdala-
anterior paralimbic neural system and possibly the
olfactocentricparalimbic cortices, as well as connections
between these regions, appear to be early features of the
disorder, lending support to a neurodevelopmental perspective
of BD (Blond et al., 2012). However, further longitudinal
studies are needed to gain support for a developmental view of
the disorder.
Quality of Life
The World Health Organization has defined Quality of Life
(QoL) as individuals’ perception of their position in life in
context of the culture and value systems in which they live
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and in relation to their goals, expectations, standards, and
concerns (WHO, 1995). Due to their illness, the quality of
life for individuals with BD is characterized by lower wages,
higher unemployment, work absenteeism and disability, marked
interpersonal relationship instability and higher divorce
rates, lower levels of educational attainment, and higher
rates of arrest, hospitalization, and premature death compared
to the general population (Steinkuller & Rheineck, 2009).
QoL is affected in an intricate and labyrinthine way by
both internal and external factors. There is no gold standard
as to what constitutes QoL, as it can be highly subjective,
therefore qualifying it as a challenging outcome measure to
reliably and accurately quantify. However, there is a growing
body of evidence that QoL is a unique and compelling indicator
of patient wellbeing, sensitive to various and relevant
domains of the patient’s life (Michalak et al., 2006; Michalak
et al, 2007; Rowe & Morris, 2012; Whisman, 2007). Unlike
disease-specific measures, QoL measures can take into
consideration such factors as the patient who has had
significant symptom reduction, but is still not ready to
return to work, or the impact the medication’s side effects
are having on the patient’s day-to-day functioning. Per the
World Health Organization’s definition, individual’s goals,
expectations, standards, and concerns play a large part in
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defining QoL, and these are each idiosyncratic, individualized
areas. Highlighting the patient’s perception of QoL can allow
for a more patient-centered approach, where the patient is no
longer at the periphery of assessing the effectiveness of
treatment interventions. Interventions can be increasingly
successful, and the doctor-patient relationship can be a more
collaborative process.
With QoL deriving from a biopsychosocial model and
traditional symptom measures deriving from a medical model, it
seems the two paradigms would complement each other in the
treatment of bipolar patients; however, they have often been
in conflict. In some settings, QoL is derided as a sort of
secondary measure of the ‘real’ targets of psychiatric
intervention. Conversely, symptom measures have been
criticized as ignoring the fact that psychiatric symptoms have
little meaning outside the context of the person experiencing
them (Murry & Michalak, 2012).
Despite advancements in the pharmacological treatment of
BD, most bipolar patients cannot be maintained on drug
treatments alone, and the impact of the bipolar patient’s
symptomatic state on QoL is great. Up to 50% of bipolar I
patients do not recover from acute manic episodes within 1
year, and only 25% achieve full recovery of function. Patients
spend as much as 47% of their lives in symptomatic states,
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specifically depressive states (Miklowitz, 2008). The majority
of studies show that, even when euthymic, bipolar individuals
have significantly impaired QoL across a variety of domains.
It has been suggested that mental disorders are affiliated
with considerably more deterioration in health related quality
of life (HRQOL) than medical disorders and that there is a
patent prototype of impairment linked to numerous mental
health disorders. This further underscores the importance of a
patient’s perception of their QoL in their case
conceptualization and treatment plans. Bipolar patients are
suffering greatly, and recovery is minimal for many.
Clinicians’ sole focus on traditional measures of recovery
neglects a large piece of what could make the difference
between another hospital visit and lasting progress. The
clinical recovery that allows discharge from the hospital or
that demonstrates the medication is having an impact is
significant, however there are other contributing factors.
Depressive episodes of BD have been getting increased
attention in the literature, as existing data suggests that
for bipolar individuals, QoL is negatively correlated with
depression. As previously mentioned, a considerable proportion
of the comorbidity and mortality in BD appears to be the
result of the depressive phase as opposed to the hypomanic or
manic phases (Michalak et al., 2008). For example, an
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individual experiencing an acute depressive or mixed episode
is at a significantly higher risk of suicide compared with an
individual experiencing a purely manic episode (Michalak et
al., 2008). Pharmacological treatment for a depressive phase
of BD appears to be particularly challenging, and has been
considered a highly controversial area of practice and
research for clinicians, frequently met with hesitation for
fear of increasing the risk of antidepressant-induced cycle
acceleration (Bowden et al., 2012; Sajatovic et a., 2009).
Additionally, while medication to treat BD can be of great
benefit in terms of minimizing or alleviating certain
symptoms, it can also be associated with lethargy, sedation,
physical morbidity, and increased mortality, decreasing QoL as
well as the likelihood for medication compliance (IsHak et
al., 2012). This further emphasizes the importance of
comprehensive treatment interventions that consider the QoL of
the patient when balancing risk-benefit ratios.
In an in-depth qualitative study conducted by Michalak et
al. (2006) to describe patients’ experiences of how BD has
impacted their QoL, 52 interviews were performed with bipolar
individuals, their caregivers, and healthcare professionals.
Many participants described their experiences to regain their
independence within their family due to family members’ over-
vigilance for recurrence of symptoms. Numerous participants
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also mentioned their difficulty in establishing independence
from the healthcare system in terms of a lack of ability to be
proactive or respected as a participant in their own
healthcare decisions. Almost all of the participants described
experiences of stigma or marginalization in relation to their
disorder, particularly in occupational settings, as well as
damage in their relationships created while in a depressive or
manic episode. At the end of the interview, participants were
asked to produce a list in ranking order of the three things
they considered the most important in determining their QoL.
An overwhelming 60% ranked social support as number one,
mental health in second place, followed by financial status,
vocation, and independence (Michalak et al., 2006).
Those with BD may suffer with social impairment due to
the behavioral changes born from depressive and manic or
hypomanic episodes, a potential consequence of which can lead
to occupational dysfunction. Several studies have indicated
that BD can have a critical impact on an individual’s ability
to function in the workplace, impeding their ability to engage
in meaningful, satisfying, or goal-related activity, paid or
unpaid, consequently impacting their QoL (Castanho de Almeida
Rocca et al., 2008). Michalak et al. (2007) interviewed 52
people with BD, their caregivers, and healthcare professionals
from a variety of employment situations, ranging from people
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with no employment history to highly skilled professionals, to
determine the impact BD has on occupational functioning. Five
main themes emerged from the data. The first theme was a lack
of continuity in work history, where cycles in participants’
work lives reflected cycles in participants’ moods (that is,
depression and mania). The second theme was loss of time due
to illness (that is, hospitalizations, having to reduce number
of hours worked). The third theme that emerged was illness-
management strategies in the workplace; the fourth was stigma
and disclosure in the workplace, which usually resulted in
participants being held back in some way, or even being fired.
The last theme was interpersonal problems at work, usually
stemming from social isolation or withdrawal during a
depressive episode, or irritability or volatile behavior when
hypomanic (Michalak et al, 2007).
Another consequential area of social or interpersonal
dysfunction is with romantic partners or spouses. While
bipolar individuals with strong support systems and supportive
partners experience less depressive symptomology over time,
the opposite is also true for hostile or critical partners
(Rowe & Morris, 2012). Bipolar individuals are less likely to
be in committed relationships or get married than the general
population, and those who are in committed relationships or
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marriages are more likely to experience relationship distress
and ultimately disunion or divorce (Rowe & Morris, 2012).
Rowe and Morris (2012) recruited a sample of 38 bipolar I
and bipolar II individuals and their partners for a study of
the symptoms of BD and relationship functioning. Results of
the study revealed that depressive symptoms of the bipolar
individuals were associated with poorer relationship
functioning, particularly when the partner without BD also had
elevated depressive symptoms (Rowe & Morris, 2012). In a study
conducted in 2007, data from the National Comorbidity Survey
Replication evaluated the associations between marital
distress and Diagnostic and Statistical Manual of Mental
Disorders Axis I disorders in 2,213 individuals (Whisman,
2007). Results indicated that marital distress was associated
with anxiety, mood, and substance disorders, with the
strongest associations obtained between bipolar disorder,
alcohol use disorders, and generalized anxiety disorder
(Whisman, 2007).
The body of research addressing QoL is growing as
researchers and clinicians recognize that QoL outcomes are at
least as valuable as clinical outcomes to successful treatment
of BD. Patient outcome in BD has traditionally been determined
by the assessment of objectively measured clinical
information, such as rates of relapse or degree of symptom
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reduction. QoL is a new, subjective area of research focusing
on patients’ perceptions of their position in life in relation
to where they want to be. QoL encompasses an individual’s
psychological, social, and physical wellbeing, along with his
or her ability to function in the ordinary daily tasks of
living, such as in the workplace or at school.
Treatment
Criteria for the diagnosis of a mental disorder entail
both the presence of symptoms as well as functional
impairment. Logic follows that remission entails both the
resolution of symptoms as well as functional improvement.
However, remission has been defined in symptoms terms only
(McGlinchey, Posternak, Friedman, Boerescu, & Attiullah,
2006). Conceptually, the return to normal functioning should
be as fundamental to the construct of remission as symptom
resolution as the contemporary approach of diagnosing
depression, as delineated in the DSM-5, requires both the
presence of symptoms and impaired functioning (American
Psychiatric Association, 2013). Analogously, for a disorder to
be in remission, each of the defining features of that
disorder should be absent. Yet, in both treatment studies, as
well as in the diagnostic manual, remission is defined solely
in term of symptom resolution (McGlincheyet al., 2006). This
disconnect may steer the direction of the formulation of the
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treatment plan. Perhaps, instead of a treatment plan that
considers the patient’s role as a wife and mother, the
therapist will focus and design treatment based upon symptoms
such as the patient’s insomnia, racing thoughts, or substance
abuse.
Clinical experience suggests that there is sometimes
discordance between assessments of symptom severity and
functioning. Some patients with minimal or no symptoms of
depression fail to return to their normal level of
functioning. Consistent with this, some studies have found
that recovery in functioning lags behind symptom resolution
(McGlincheyet al., 2006). For example, a patient may no longer
fit criteria for a manic episode, but may still be an unfit
parent. Similarly, a patient may be hypomanic but continue to
function normally in his or her role as a student. This sole
focus on symptom reduction not only seems flawed, but also
effectively removes the patient’s QoL from the clinical
picture. The primacy of symptoms as outcome measures is a
deduction from an organic disease model, which assumes that
symptoms have a one-to-one relationship with an underlying
pathological entity that is the target of treatment. Measures
of QoL, by contrast, are consonant with a biopsychosocial to
BD, in that they prioritize patient agency, context, meaning
making, and lived experience (Murray & Michalak, 2012).
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While guidelines remain varied, pharmacotherapy remains
the treatment of choice for the treatment of manic/hypomanic
and mixed episodes. First-line treatments such as lithium,
valproate, or atypical antipsychotics are generally initiated,
while antidepressant medication is discontinued (Niovli et
al., 2011). However, antidepressants continue to be widely
used, acutely and long term, to treat bipolar depression
despite the paucity of evidence to support this strategy
(Bowden et al., 2012).
A 2009 study evaluated the perceived treatment effects,
concerns, and expectations among 90 individuals with BD
(Sajatovic et a., 2009). Results indicated that, while 39% of
participants denied medication concerns, nearly 29% feared
possible long-term effects, such as consequences to their
physical wellbeing. While individuals with BD appreciate the
effects of medications, the concerns regarding adverse effects
and discrepancy between actual and hoped-for outcomes can be
substantial (Sajatovic et al., 2009). It is perhaps not
surprising that many patients struggle with medication
adherence.
Frank et al. (2000) stated that BD is a disorderly
illness. That being said, they observed that it is
“characterized by erratic sleep–wake cycles and dramatic
symptom fluctuations, the clinical course is unpredictable and
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rarely static” (p.594). The main conclusion that could be
drawn from this statement is that BD is a moving target, which
means that the state is never constant. Because of that, the
treatment of this disorderly disorder poses interesting and
sometimes problematic challenges (Frank et al., 2000). Sachs
et al. (2000) supported this idea when they said that as
individuals with bipolar disorder move along the stages of the
disorder, the clinicians treat them with a wide range of mood
stabilizers in combination with neuroleptics, sedative-
hypnotics, and antidepressants. Frank et al. (2000), however,
maintained that lithium monotherapy is still the most
effective treatment of pharmacotherapy for bipolar disorder.
Summary
Investigation into the literature of BD has painted a
clear and conspicuous picture of both the depth and profundity
of the disorder, as well as the importance and implication of
its treatment. The confrontation of this disorder, both by
patient and therapist alike, undoubtedly involves the
patient’s QoL. The impact of BD on QoL has been researched and
validated leaving room for the investigation into how QoL fits
into the architecture of the treating psychologist’s treatment
plan. Currently a dichotomy between the biopsychological mode
and traditional symptoms measures exists, leaving much desired
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 The main purpose of this qualitative case study was to
investigate clinical psychologists’ integration of the quality
of life (QoL) construct into their treatment of bipolar
patients. Participants were recruited from local agencies
i.e., The Santa Barbara County Psychological Association, as
well as through connections through fellow mental health
professionals, university professors and colleagues who
forwarded the Recruitment Letter (Appendix A) on to therapists
who fit the criteria outlined in the Recruitment Letter. The
primary criteria indicated that a participant must be a
licensed psychologist and must have treated at least one
bipolar patient in the past.
Seven women and two men, all of whom reside in Santa
Barbara, California, were interviewed independently, either in
their office or over the phone. As individuals demonstrated
interest in the study (via phone call or email), it was
communicated that it was the aim of the researcher to make the
process as convenient and comfortable as possible for the
participant and that the interview would take place at a
location of the participant’s choice. All participants signed
an informed consent form prior to their interview (Appendix
C), which included a brief synopsis of the purpose of the
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study as well as outlined confidentiality. The participants in
this study were not compensated financially for their time.
Each interview took approximately thirty to sixty
minutes. At the beginning of each interview, a hard copy of
the Consent Form (Appendix C) was briefly taken out, in the
case of the face-to-face interviews, or referenced in the case
of the phone interviews, and the participant was asked if they
had any last questions or concerns. Though it was indicated in
the Consent Form that the interview would be audio recorded,
the researcher re-confirmed the participant’s permission to be
recorded. Participants then proceeded to answer a battery of 6
pre-determined, open-ended questions in order to help the
researcher identify perceptions and explore the insights and
beliefs into the integration of QoL into the participant’s
treatment of their past or present bipolar patients. Data were
collected from this questionnaire, transcribed, categorized
for commonalities, and then interpreted.
During reporting, no identifying names were used or
recorded. In order to further protect the confidentiality of
the participants, pseudonyms have been used in place of names,
any identifying information has been altered, and all data has
been kept securely in a locked filing cabinet.
This study attempts to understand the process of
therapists’ treatment of bipolar patients, how QoL is
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integrated into the treatment plan and ultimately utilized as
an outcome measure. . The interview questions were the
following:
1. Where did you learn to treat bipolar disorder?
2. What do you consider to be the three most important
factors in treating someone with BD?
3. What has been your experience with bipolar patients and
their understanding of their disorder?
4. What are your thoughts on the idea of “clinical” recovery
versus “functional” recovery?
5. How do you integrate the quality of life into your
treatment?
6. What have you noticed when integrating this construct in
your treatment plan?
Procedures for the Study
1. Recruitment of participants was accomplished via
professional associations and referral.
2. The location for six interviews took place in the
office of the therapist, while the remaining three
interviews were conducted over the telephone. All
locations guaranteed confidentiality to the extent
they were already rooms designated for confidential
therapy by the therapist him- or herself, or the phone
call was conducted in a closed room with limited
access from the outside.
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3. Participants were required to sign an informed consent
form prior to being interviewed. For the three
participants that were interviewed over the phone, two
participants were mailed pre-addressed materials in
order to mail the consent form back to the
researcher’s address, and one faxed the consent form
via confidential fax.
4. Interviews conducted consisted of 1:1 30-60 minute
data collection interview conducted by the researcher
with the participant.
5. The data collected was interpreted via standard
qualitative data analysis procedures, such as noting
similar phrases, patterns, themes and common
sequences.
Data Processing Techniques
The study was conducted using a qualitative design, where
the participants were asked open-ended questions regarding
their goals and experiences of therapy with people who have a
diagnosis of BD. “One of the advantages of this approach is
the close collaboration between the researcher and the
participants, while enabling participants to tell their
stories” (Baxter & Jack, 2008). As opposed to quantitative
studies that are limited by narrowly defined variables (Berg,
2004), using a qualitative approach was determined to be the
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most appropriate for this study. The use of a qualitative
approach allows the researcher to collect data specific to a
particular context in order to understand an issue (Nakai,
2012). Data was interpreted, as opposed to merely hypothesis
testing, with the goal of both arriving at a comprehensive
understanding of therapists as well as developing theoretical
statements about their treatment of bipolar patients (Marriam,
1998).
As a qualitative method, the bounded case study was
determined to be suited for the purpose of the study. “A case
study is an empirical inquiry that investigates a contemporary
phenomenon within its real-life context, especially when the
boundaries between phenomenon and context are not clearly
evident” (Marriam, 1998). Through careful investigation and
research, it was felt that the case itself would reveal much
about the integration of QoL and what it represents, as the
therapist is on the front line and can accurately provide a
holistic illustration of all factors involved in their
decisions, such as how they integrated QoL, what happened, and
why.
As “an intensive, holistic description and analysis of a
single instance, phenomenon, or social unit,” a qualitative
case study was been determined to be the best method in which
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to study psychologists and analyze their treatment of their
bipolar patients (Marriam, 1998).
This particular study focused on the process used by
clinical psychologists in determining how to integrate QoL
into the treatment plan of patients with BD. There are four
possible applications of the case study model (a) to explain
causal links between the therapist’s individual experience and
interpretation of the disorder and how current QoL can be
integrated into the treatment plan, (b) to describe specific
cases wherein QoL was integrated into treatment plans (c) to
identify the factors that may necessitate the inclusion of QoL
into treatment plans for patients with BD, and (d) to describe
the manner by which QoL was integrated into the treatment
plan.
A qualitative bounded case study has provided the
opportunity to gain as much information about the problem as
possible with the intent of analyzing and interpreting the
phenomenon, complete with all of the factors that contributed
to it. Carefully formulated research questions, informed by
the existing literature and a prior appreciation of the
theoretical issues and settings were all important in the
selection of the population (Crowe, Cresswell, Robertson,
Huby, Avery & Sheikh, 20011). The use of open-ended interviews
facilitated the exploration of the therapists’ integration of
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QoL in their treatment by allowing them to describe their
views of reality, fostering a clearer understanding of the
participants’ actions (Baxter & Jack, 2008). A collective case
study, using multiple cases, provided a general understanding,
as well as a detailed description of each case allowing the
researcher to unearth a theme within cases.
Methodological Assumptions and Limitations
As the study population consisted of licensed, clinical
psychologists currently practicing in the small community of
Santa Barbara, this limited the variability of the
participants and the generalization to the larger population.
Further research in other locations will further test the
hypothesis of this study.
Ethical Assurances
Stringent measures were taken to preserve the privacy of
the participants and the confidentiality of the data they
provided. Prior to conducting any data collection procedures,
the participants were asked to sign an informed consent letter
(Appendix C). The informed consent letter clearly reiterated
the purpose of the study and indicated the nature of the
participation. The participants were informed that all
interviews would digitally audio-recorded for data collection
and analysis purposes. Procedures to uphold data and
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participant confidentiality were similarly explained before
the commencement of all the interviews.
To protect the privacy of the participants, the digital
audio recordings of the interviews were labeled with initials
to avoid revealing the identities of the study participants.
They are referred to with pseudonyms in all of the notes and
write-ups included in this study. In addition, interviews were
conducted individually, and scheduled in a manner that
prevented participants from coming into contact with each
other. This protected their participation from being
discovered by fellow colleagues who may also be participating
in the study. A master list of the participants has been
locked in a separate location from the data.
All hard copies of the data are stored in a locked filing
cabinet inside the researcher’s office. Similarly, all
electronic data is secured by a password that is known only to
the researcher. The back-up copy of the electronic data, which
is stored in a password-protected flash drive, is being kept
with the rest of the hard files in the filing cabinet. All




For this study, two men and seven women were interviewed.
All participants are licensed clinical psychologists residing
in Santa Barbara who have treated at least one bipolar patient
since licensure. The participants were asked six open-ended
questions during the interview in order to facilitate an
understanding of how therapists treat their bipolar patients,
how they integrate QoL into therapy, and what the outcome of
this integration is. The subsequent vignettes are accounts
derived from the individual interviews.
Dr. Abby
Dr. Abby stated that her training with BD has been a
progression. A rare diagnosis in the seventies, her
development as a therapist has especially evolved in the 25
years she has spent in private practice. Most of her work now
is in private practice, where she does a fair amount of work
with patients struggling with severe mental illness, including
BD. When asked to detail primary factors in treating bipolar
patients, Dr. Abby stated the following three at the top of
her list when first treating a bipolar patient: stabilization
on medication, exploration of interpersonal relationships, and
educating the patient on the long-term nature of their
disorder.
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She characterizes herself as a psychoanalytic therapist,
and will take spend as much time as needed with self-
exploration and analysis.
Dr. Crandle
Dr. Crandle stated that he did not receive any formal
training on how to treat BD in graduate school. However, he
was mentored in differential diagnosis during his post-
doctoral training, and it was this hands-on experience with
bipolar patients that he considered his first, real adequate
training. Dr. Crandle currently has a private practice, as
well as leads several groups. He is very active in treating
geriatric patients suffering from mental illness. In his
private practice, he stated the first step he takes in
treating a bipolar patient is to educate him or her about
their condition, as he feels a lot of patients do not
understand they are bipolar.
Dr. Ender
Most of the information provided from participant Dr.
Ender was reflection on a past patient he treated whom he is
still in contact with. He treated this patient for several
years, until the patient moved away. While Dr. Ender no longer
treats this patient, the patient will periodically check in
with participant him, and this is a welcomed interaction. Dr.
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Ender described this patient as “bipolar in order,” stating
that the patient has gone on to thrive in his community
without medication, is holding down a job, is participating in
a healthy relationship, volunteers, and is once again
painting, which was a hobby he had previously given up prior
to beginning therapy. Dr. Ender described this case as being
very inspiring and one that has given him much pride in his
career, as well as one that has provided him with much
education in the area of BD and the possibility of not taking
medication.
As both a professor and a therapist, it is experiences
like this one that Dr. Ender credits with “feeding” his
career. Although his specialty is hypnosis, Dr. Ender
regularly uses what he termed a “kitchen sink approach” to
therapy, in which he will pool together all of his tools,
skills, and experiences in order to best treat his patients.
Dr. Grant
Dr. Grant reported that she did not have any formal
training for bipolar disorder, and all of her experience was
gained during her hands-on postdoctoral work. Dr. Grant
expressed a lot of discomfort around explaining her diagnostic
process, indicating there was a lot that went into determining
whether or not a person, indeed, had BD and this could not be
hypothetically described. However, Dr. Grant stated that
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medication is the primary goal for treatment when treating a
bipolar patient. “I always go for the medical thing first,”
she stated. Most of Dr. Grant’s report came from her
experience with one patient she is currently seeing, whom she
describes as also possibly having a personality disorder as
she uses her BD diagnosis to her advantage, manipulating other
doctors for medication and resources in the community.
Dr. Ivans
Dr. Ivans received training on BD in graduate school and
in her clinical training. She then went on to train in
positive psychology. Dr. Ivans described herself as a
Monastic. When treating patients with BD, she reported the
most important piece in treatment is psychoeducation. She then
went on to say that the second most important piece of
treatment is self-regulation.  Dr. Ivans made it clear that it
was very important to her that each patient was evaluated on a
case-by-case basis, that due to the individuality of each
patient, she proceeds with caution and care, even in her
diagnosis and psychoeducation.
Dr. Kelly
Dr. Kelly stated that she did not receive any formal
training in BD, and frankly did not receive very much guidance
when it came to severe mental illness. When asked about her
treatment, Dr. Kelly stated the three most important factors
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she focuses on is medication compliance, symptom management,
and tracking the patient’s level of contentment in order to
provide him or her with more of a sense of control. She is not
currently treating anyone with BD, however she has treated
several patients in the past with BD, many of whom have also
struggled with addiction, which is her specialty.
Dr. Mount
Dr. Mount gleaned most of her experience through dually
diagnosed patients that had both BD and substance abuse. In
her treatment, Dr. Mount stated it was most important to focus
on the patient’s safety, and to make sure they are
“contained.” Through her work with dually diagnosed patients,
Dr. Mount stated a lot of patients were not aware of their
diagnosis and were using substances to self-medicate. Dr.
Mount reported it would become very important to educate
patients about their disorder in an effort to prevent relapse.
Dr. Perin
Dr. Perin felt very strongly against medication for her
patients. She does not take insurance in order to avoid having
to diagnose patients, and in the event she does have to
formally diagnose she provides the same diagnoses for all as
she does not feel that labeling a patient with a disorder is
useful. 
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Dr. Perin stated that the she feels the immediate
referral to a psychiatrist to get on medication conveys the
message to the patients that “I cannot deal with you unless
you’re drugged.” Her primary goal in treatment centers around
the formation of a strong therapeutic relationship where the
patient feels safe and encouraged to explore what has brought
them to therapy.
Dr. Rourke
Dr. Rourke obtained the majority of her experience with
bipolar patients from her work conducting emergency room
intakes, and during her post-doctoral supervision. When asked
what her top priorities are when treating a bipolar patient,
Dr. Rourke stated, “establishing rapport, trust, and having an
interest in what they’re saying is the most important part of
my work with patients.” Dr. Rourke is not currently treating
anyone with BD as she is currently in a phase in her practice
where she would like more of a “mutual process” with patients
who have more insight into their pathology, have a strong
motivation for change, and do not require long-term care.
The Integration of Quality of Life
The objectives of this study were to explore the
integration of the quality of life in therapists’ treatment of
their bipolar patients. The researcher hopes the findings of
this study will prove useful to both therapists and patient
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alike by illuminating how therapists treat their bipolar
patients, how they integrate QoL into therapy, and what the
outcome of this integration is.
As the interviews proceeded and themes emerged,
categories formed that began to define the construct of the
integration of QoL into the treatment. These included: (a)
medication; (b) the therapist’s perception of the bipolar
patient; (c) the importance of the therapeutic relationship;
and (d) the integration of QoL into the treatment plan.
Medication
Dr. Abby discussed her experience with bipolar patients,
and described her primary goals in treatment as follows:
First I work on getting them connected with a good
psychiatrist and helping them to stabilize on medication,
because it is a very complicated process to stabilize a
patient on medication. Once that stability has been
accomplished I think it’s very important to look at their
interpersonal relationships and see how disruptive they
have been. I try to work with them on trying to
consistently hold in mind that this is something they
will have to work on long term. I work with them on how
to accept that this is something more than a transitory
depression or a passing manic phase. But without
medication ... a true bipolar person, it just won’t work.
Dr. Abby posited that beginning her work with a bipolar
patient cannot truly begin until they have started medication
and, in fact, starts with the process of working with the
patient to either begin taking medication or refining
medication compliance. Only then can the work develop further
into facilitating introspection into interpersonal
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relationships, and further understanding the nature of their
disorder.
When discussing the bipolar patient’s clinical recovery,
participant Dr. Crandle described the importance of medication
stating, “Clinically, medication is key. We solve the problem
of bipolar by placing people on medication. Which is not easy.
It doesn’t become my job as a psychologist, but I do
collaborate with the psychiatrist or the patient’s general
practitioner.”
While Dr. Ender encouraged the patient he reflected on
during his interview to speak with a psychiatrist, he also
reported “fielding his feedback about his medication” as part
of their therapy. This process involved discussing the
patient’s experience of his medication, as opposed to
approaching the situation with a pre-fabricated decision on
whether or not he should be medicated. Through this process,
Dr. Ender reported that he came to understand that medication
was not the best option for this particular individual. This
patient was not medication compliant as it was and it became
evident to Dr. Ender that it would be more conducive to
therapy to focus on other means of treatment, which were
successful. “He is what you can call bipolar in order, “ Dr.
Ender reported, stating that while the patient is still
considered bipolar, he is able to hold down employment, have a
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satisfying long-term relationship, he is a volunteer in the
community, and is partaking in hobbies he had not been when
they first met. “He did not like being emasculated from his
experience, he did not like the medication because of that,”
Dr. Ender described.
Dr. Grant described her treatment plan as beginning with
a discussion about medication, and “always going for the
medical part first.” She expressed empathy for patients who do
not want to take medication, or do not want to hear that they
need medication, and her tactics for getting them to at least
try it for a while. “I think somehow there is a stigma in
society that is damaging to their egos,” She said. “I mean,
most people don’t want to take a medication at all let alone
for the rest of their lives. Diabetics often don’t take their
medication. So if I can just get them on it for a while so
they can see the difference, I think that’s an
accomplishment.”
Dr. Ivans was hesitant to mention medication as a part of
her treatment plan. Rather, she stated that she works on
“self-regulation” with her patients, which encompasses mind-
body skills, planning and activities of wellness. She
indicated that medication may be encompassed in the self-
regulation piece of therapy. When asked specifically if she
supported medication, Dr. Ivan’s response was as follows:
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My experience with people has to do with finding enough
stability to do the work. So I guess the best answer I
can give you is maybe. To the degree that the medication
is needed, to be able to do the work, to create
stability, I would say yes. But across the board, I think
that has to do more with the individual.
Dr. Kelly reported that one of the most important factors
she focuses on when beginning treatment with a bipolar patient
is medication compliance. She expressed much support for
medication, stating, “I’m not entirely sure that when you meet
full criteria, un-medicated, a rich and juicy life if
possible. Even with quite a bit of insight.”
Most of participant Dr. Mount’s work with bipolar
patients came from her time at a substance abuse center, and
as such a lot of her responses reflected experiences with
patients who were dually diagnosed. She spoke of medicated
patients who, thinking they were now cured, would suddenly
stop taking their medication without the support of their
doctor(s). She saw this leading to eventual relapse as a lot
of her patients would consequently reach for other substances
to self-medicate when the depression or mania would inevitably
strike.
Dr. Perin felt very strongly against medication. In fact,
she does not accept insurance in an effort to avoid the formal
diagnoses process. In the event diagnosis is ever required,
she provides all patients with the same diagnosis. She
indicated she has noticed, experienced, and been told about a
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great deal of corruption both with the pharmaceutical
companies and psychiatrists, but it was mostly her experience
with patients that drugs hampered the recovery process. It
created new problems for patients, such as anxiety surrounding
whether or not it would be possible to stop the medication or
the copious amount of side effects, and impacted the
therapeutic relationship by sending the message to the patient
that work could not begin until they were drugged. Dr. Perin’s
strong feelings surrounding medication has led to her
involvement in groups that help spread the word that
medication is not the only way to treat severe mental illness.
Dr. Rourke stated that she does not work from a medical
model and, while she does feel the medication may be necessary
in some instances, she is more interested in her patients’
every-day lives.
The Therapist’s Perception of the Bipolar Patient
Dr. Abby recalled when she first revealed her diagnosis
to her patients and how difficult that can be for some, which
can result in resistance to accept their bipolar diagnosis as
accurate.
With the informational resources available to most people
today via the Internet, they can easily start researching
their diagnosis, and most people don’t like what they
read. Of course it’s not wonderful news, and there is a
degree of resistance in that they don’t want to think
about ‘this is something that has manifested in me, I
always got by fine in the past.’ In general, yes it is
resistance.
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Dr. Abby expressed the importance of the consideration
that this may be a big blow to a person’s perception of who
they are and what the rest of their life may now look like.
Dr. Abby’s expression of concern translates into her practice,
where she works with her patients’ resistance.
Dr. Crandle stated that he does not feel that most
patients have a clear understanding that they a bipolar.
Additionally, Dr. Crandle realized and that admitting to a
bipolar diagnosis can be “a tough pill to swallow,” and may
require “some easing into.” He therefore feels it extremely
important to support his diagnosis to his patient’s with
evidence.
And it’s really important for me to have clear evidence
of identification, and then to use the behavioral
material to educate the client that they are indeed
bipolar. I have a three rule: I have to notice something
three times in order to be able to provide an
interpretation that carries some strength. So when I see
a pattern three times, so then I feel I am in a position
to say I see a bipolar process.
Through his long-term therapy with the bipolar patient he
referenced in his interview, Dr. Ender mentioned in particular
the amount of inner strength it took for him to remain patient
in the face of the many “unreasonable” things his patient did
during the course of a manic episode. “There were some times
when I actually got pretty firm with him in therapy and had to
draw a line and say this is not okay, and it’s not acceptable
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and I’m very disappointed. Almost like a parent,” Dr. Ender
recalled.  “And I look back on that and think, how could he
still like me? But it’s been a success.”
Dr. Grant reported diagnosis and assessment being very
integral to her process as her treatment immediately with
treating the medical aspect of the disorder. “They have to
understand they have a biochemical illness,” she explained.
Dr. Grant expressed confusion as to why some people are
successful with medication and therapy, and some people are
not.
Dr. Ivan’s described herself as a very spiritual person
at heart, which in turn shaped her view of her patients.
My fundamental lens is that people have a way of flowering,
just like plants do, and some are going to flower well and
some are not going to flower well, and it’s all according
to the care they’re given. And sometimes plants that don’t
flower well we can resuscitate and sometimes we can’t. Now
I’m speaking to that at a psychic level. So I very clearly
see a differentiation between functional and medical
recovery. And I think that’s where the art of
psychotherapy, and really good therapy comes in. Because
that’s built on so many nuances.
Dr. Ivans attributed her same nature for her hesitation
to clinically diagnose patients. She reports noticing a lot of
stigma surrounding BD and has not noticed benefits in labeling
her patients. Instead, she “stays with the feeling of what is
going on” rather than a “blanket statement.”
Some people very much want the black and white answer,
and they’ll come in and give me the laundry list, and
they’ll give me all the things they think they are. And
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of course they’re grasping to cognitively understand. But
I’m very careful. I’m not real big on labels. Monastics
on not real big on clinical diagnosis. Some people will
unravel; they will go down the Internet hole,
catastrophizing and then we’ll have even more of a mess.
Dr. Kelly described her bipolar patients as being
completely overcome by their disorder, many turning to drugs
and alcohol to mimic the mania they do not want to give up.
Additionally, diagnosis could be especially difficult for some
to accept:
I remember at times people being somewhat relieved, that
things made more sense to them, that their behavior made
more sense to them. I remember responses from people that
they were quite enraged to think that they were “mentally
ill,” and that’s actually what detrimental to treatment.
Some people became quite angry.
Dr. Mount expressed that bipolar patients needed constant
monitoring as, in addition to not fully comprehending their
disorder, they were easily seduced by false recovery. Dr.
Mount reported being enlightened, however, at the role trauma
played in the lives of many of her patients.
I’ve come to understand to role trauma has played in the
origin of BD. A fight or flight state may have become hard-
wired in due to a traumatic experience and correlates to
the manic state, and how that manic state may have served a
function for them. And then helping them to realize this.
Dr. Perin feels that a lot of bipolar patients are not
recovering, making progress or are even resisting therapy due
to the messages they are being fed by labels and stigmas. She
does not incorporate medication into her practice in order to
avoid sending the message to her patients that they need to be
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drugged in order for her to work with them, and she does not
feel that a mental health diagnosis is useful, especially for
patients who are not ready to hear it.
Dr. Rourke reported being at a state in her career where she
is currently not taking on any more bipolar patients because,
as she stated, she “does not want to work with people any
longer that do not want to change.” While she recalls many
past bipolar patients as being intelligent, and some as being
very insightful, the amount of work and patience it took to
make progress was something she had the energy for in the
past, and does not currently desire as she winds down her
practice.
The Importance of the Therapeutic Relationship
Dr. Abby spoke about the importance of her relationship
with her patients and how, due to the nature of her
therapeutic orientation, she was able to convey to them that
she was always available.
Because I mostly do long-term therapy, that means that I
am consistently there for people. Even after the first
significant period of work that we do together. We
usually taper down therapy, but even after we taper off
they know I’m still around. So there are some people I’m
at the point I see once a month, once every two months.
Some people will come back a year later for a couple of
sessions. But it builds then on the work we’ve done
before, sort of like a tune up to try to help them deal
with a current issue or get back on track. And I think
that’s where therapeutic relationship is so important bc
they know I’m here. They know I’m here if anything starts
to happen they know I’m here and they don’t have to start
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from the beginning. I know who they are and I can step in
to work with them again.
Dr. Crandle spoke considerably about the importance of
the therapeutic relationship to his treatment of those with
mental illness, stating that it in fact formed the basis of
his practice. He indicated that progress was not possible
without first developing the bond between the therapist and
the patient:
To me, everything comes from the relationship. So, my
work involves creating the therapeutic relationship, an
empathic tie between myself and the individual. I’m not
doing anything to them or for them, we are doing
something here together. So, through my understanding and
their recognition that I really do care and I want to
help and I am available to them, I am developing a
therapeutic relationship. And through that therapeutic
relationship I can begin to provide some information and
some perspective and ask them to look at that and
hopefully buy into that so that we can look at it
together.
Dr. Ender spoke mostly about the rapport he developed
with his patient. He described a situation where he had to
develop empathy and patience in order to both be able to
weather the storm of his patient’s manic episodes, as well as
genuinely communicate understanding and set boundaries. Dr.
Ender described his role as an advocate in the community for
his patient, helping him to obtain resources necessary for
survival and success, as what cemented their bond and showed
his patient how much he cared. This created a sense of trust
and security, which facilitated therapy. Dr. Ender described
his perspective as follows:
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The relationship is everything. They’ve known since
Norcross did his stuff, that they could not distill from
different types of therapy. The only thing that they
could distill out of comparing different kinds of
therapies was that the perception on the part of the
client on the empathy coming from the clinician was a
predictor of success. That’s it. So all of the rest of
the stuff, it’s like a medium in which you supply
empathy.
While Dr. Grant expressed much preference for immediate and
prolonged attention towards medication compliance, she stated
there is a great deal of importance in the relationship
between the therapist and the patient. “Sometimes you need a
psychologist to get you to take your meds and do it right so
that you can take the next step in your life,” she explained.
“There must be a relationship there that is based on trust,
understanding and respect in order for your patient to believe
that you know what you’re talking about and to follow any
advice you’re giving.”
Dr. Ivans described the importance of “meeting patients
where they are” in terms their ability to accept and process
information on multiple levels of consciousness. She described
the patient-doctor relationship as one that requires
sensitivity, attention to detail, and years of experience to
develop.
I have had so many people come to me and tell me they have
felt the therapists judge them. Now that may have been the
therapist’s discernment, but I know what they mean. And yet
you can be too tender and empathetic and blow the treatment
up at the same time. So meeting them where they are is a
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nuance skill, something we learn over a lifetime in this
career.
Dr. Kelly spoke extensively about the importance of having
a regulatory figure in a bipolar patient’s life. She referred
to the re-parenting process in therapy, and how the capability
of providing boundaries and safety for a person to process
their thoughts and feelings plays a large part in the success
of the patient.
I think people do much better if you are with a regulatory
figure. In other words, you can be total crazy when you’re
working with one person and completely sane when you’re
working with another. I’m not entirely sure what that’s all
about. I think an awful lot has to do with the therapist. I
realize bipolar disorder is chemical in nature, but it also
is, to some degree, attunement. And if there’s nobody
stable to attune to, how do you do manage this disease? A
feeling of yes, I belong someplace and it’s safe, will make
all of the difference. That hour should be from diagnosis
to death.
Dr. Mount spoke extensively about her personal discovery
while working with bipolar patients, and how only through
hands-on work did she truly see the pain and trauma bipolar
patients had endured in order to present with the symptomology
they were exhibiting.
Dr. Perin’s work centers all around the therapeutic
relationship. As the diagnosis and medication is not a part of
her clinical picture, she focuses solely on the formulation of
a relationship. She does not consider herself to be a
directive therapist, and therefore takes more of an
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“encouragement role,” in order to support her patient’s in
their journey of self-exploration.
Dr. Rourke stated that establishing rapport and trust with
her patients are the most important factors in her treatment.
She treats therapy as a mutual process where the goal is to
help people to change. However, she is realistic about this
process, understanding that people are only capable of what
they are capable of, and she takes this into consideration
during the therapeutic process. “I give people a good sense of
what it would be like to work with me,” Dr. Rourke reported.
“I don’t take every client I see, and not all of them take me.
It’s important for there to be a good fit.”
Progress
Dr. Abby spoke extensively about the importance of
focusing on the quality of a patient’s functional recovery.
“There is difficulty in learning how to live with certain
considerations that other people don’t,” she explained. “In
how to be in the world, how to be in relationships, how to
take care of one’s self. And that’s the functional part.”  Dr.
Abby explained that once she was able to stabilize her
patient, usually with medication, she was then able to “focus
on the quality of that function.” This included asking the
patient questions such as what they would like more of in
their life, what they would like to be different, and what
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they would like to sustain. And once they were able to make
progress in those areas, Dr. Abby stated she was then able to
move into more esoteric QoL questions that included
exploration in areas such as spiritual development, career
goals, and personal values.
Dr. Abby explained that this process was a continual one,
where she and her patient came to an acknowledgement that QoL
will always need to be reevaluated. She explained further:
The QOL of one’s life and what one chooses at 22 is not
going to be the same at 52. Along with whatever bipolar
issues may be present, there is still the social, cultural,
developmental progression. And I think this is where
patient’s realization hits that I am around for a long
time, I’ve been in practice for a long time, once they’re
my patient they’re always my patient, and they know that
“okay I’ve got someone to do this with! If I reach I point
in my life where I’m re-thinking things and what’s
important to me, I can do that with Dr. Abby!” I think
that’s very grounding for them.
Dr. Crandle spoke about how his work also involves
processing what the client capable of doing during the stages
of their progression of treatment to together. After his
patient has been stabilized on medication, Dr. Crandle then
reevaluates to see their capability to function in day-to-day
aspects as well as major functions of their life.
I will talk spend time evaluating my patients in order to
determine if they are now able to handle the major
aspects of their life. How is it going in their
relationships at home, with their child, with their
family, how are they doing at work. And equally
important, how are they doing recreationally and
socially? Are they able to find fulfillment?
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When discussing his patient, Dr. Ender spoke a lot about
the impact BD had on this man’s life, such trauma, the
substance abuse, and the aftermath of his manic episodes,
which regularly involved depression, guilt, shame and
embarrassment. Dr. Ender described his role as this patient’s
therapist as doing whatever it took to help improve his daily
functioning. Employing his “kitchen sink” method of
integrating hypnosis, meditation, neurofeedback, and fielding
his feedback about medication, Dr. Ender focused on helping
his patient to “get his bipolar in order” in a way that worked
for this individual. While Dr. Ender knew that it was against
the advice of the patient’s psychiatrist to discontinue
medication, he realized the side effects, both physical and
psychological, were detracting from his patient’s QoL and
decided against contending with his patient on that matter. He
instead worked with him to develop alternative methods of
treatment, and “was ultimately successful.”
Dr. Grant feels that medication is imperative in bipolar
treatment. Without medication, she feels progress cannot be
made in other areas. She focuses first on medication
compliance or helping her patient to get started on the right
medication, and only after improvement will then move into the
next phase of treatment.
I always go for the medical thing first. Once the mood is
even enough, then I move into the QOL stuff. I mean,
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that’s the point really. To me, that’s the work of the
psychologist.
Dr. Ivans communicated the most important aspect of her
treatment with patients is to assure she is meeting them where
they are in order to assure that she is not only treating
their BD, but treating their pain and offering relief. It is
her belief that with the relief comes relaxation, providing
the foundation for their work together.
I’ve got to find out at the heart of their matter what
they want. Again it comes back to meeting them where they
are, what’s working, what’s not working. One of the
things that I ask, at least the first time and often
thereafter, is what’s pressing against them the most.
Because that’s the ‘pain piece’ that needs to be dealt
with straight away. People come into therapy because
they’re in pain. Something is pushing them from the
inside out in their experience. So I tried to find out
what the most pressing piece is first so I can bring
close and immediate relief. And when we bring close and
pretty immediate relief, there is a trust that begins,
and they start to feel better and they can start to relax
a little bit more. And everything builds on that.
Dr. Kelly asserted her belief in the necessity for long-
term psychotherapy in order to improve the QoL of her
patients. She stated her belief that having a stable,
supportive regulatory figure in the patient’s life to
regularly attend to symptomology will dramatically improve
their QoL. “I ask them to tell me about what’s been hard this
week,” she explained, “and what can we try that might be
different. I ask them where they are in this process, what’s
one thing that made them grateful or happy this week.” Dr.
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Kelly wonders what the impact of having a stable, dependable
regulatory figure in the life of bipolar patient from day one
could do in terms of the presentation, as she feels that
almost all disorders, including BD, can be boiled down to
complications in the patient’s development and adjustment
formations.
There was no parenting, no self-regulating, for many of
these patients, and it is not the fault of the individual
if no one ever said to them, ‘sometimes we’re up,
sometimes we’re down, but when we’re down what do we have
to do today to make things brighter?’ Or ‘I promise you
that this feeling will go away, because feelings do go
away.’ They are the most un-parented people imaginable.
Dr. Mount expressed that safety is a primary concern for
the bipolar patients in her current milieu. When discussing
treatment, she stated that almost all of her bipolar patients
did lack awareness into their disorder. Rather, they enjoy the
feelings that come with their mania and will do what they can
to preserve it. Her treatment goals encompass individual and
group therapy to provide education, tools for exploration and
behavior modification in order to prevent self-medication,
depression following manic and hypomanic episodes, and improve
the lives of her patients. In her words, it all focuses on the
quality of her patients’ lives as their self-containment and
sobriety will determine their next step.
Dr. Perin described a patient who could get through a day
without feeling suicidal, however she could not get through an
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hour without having to pop a pill in her mouth. “What kind of
life is that?” she asked. “She doesn’t want to kill herself,
but her family is afraid for her safety, she is afraid of
everything and she has an extremely low QoL.” Dr. Perin’s
treatment sometimes centers around helping patients deal with
the anxiety and fear they feel about stopping medication, and
then how to cope with their disorder without it. Her focus is
then put into letting her patient drive the therapy by telling
her what they want and need in order to live a happy life. She
attunes to resistance, and will process what the patient can
handle as they can handle it. Her modality is not about
forcing treatment, but rather paying attention to what her
patients’ needs are.
Dr. Rourke stated that she pays close attention to her
patients and listens attentively in order to provide a solid
base for treatment. According to Dr. Rourke, this enhances
rapport and promotes honesty in the therapeutic relationship,
which in turn assists her in her development of a treatment






Seven women and two men residing in Santa Barbara,
California described their experience treating bipolar
patients from a variety of perspectives in response to six
open-ended questions posed by this researcher. Questions aimed
to identify how therapists treat their bipolar patients, the
integration of QoL into the treatment plan and what the
outcome of this integration is. Through the course of
analysis, four major themes emerged: medication, the
therapist’s perception of the bipolar patient, the importance




Dr. Abby, Dr. Crandle, Dr. Grant, Dr. Kelly, and Dr.
Mount all support medication as their first line of treatment,
delineating it as an imperative first step needed before
further progress in treatment, such as self-exploration or
reparation of social relationships, can be made. The remaining
participants, Dr. Ender, Dr. Ivans, Dr. Rourke and Dr. Perin,
described their approach as “meeting [their] patients where
they are” in order to focus more on other aspects of treatment
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such as resistance, self-regulation, self-exploration, or even
medication cessation as opposed to prescription. The latter
participants described medication being either less a part of
or not a part of the treatment plan, with their focus more
towards the patient’s presentation.
The Therapist’s Perception of the Bipolar Patient
The participants all agreed that their patients lacked a
comprehensive understanding or clear insight into their
disorder. Participants described manifestations of resistance
in therapy that stemmed from the patient’s difficulty to
accept the magnitude of conceptualizing their disorder. Some
participants felt it better not to use labels, such as BD, or
chose to hold off on diagnosis until it was determined the
patient was stable enough to develop the necessary coping
skills to handle the news of their diagnosis. The therapists
all agreed that bipolar patients are a very challenging
population to work with and one that takes a special degree of
care.
The Importance of the Therapeutic Relationship
All participants mentioned the importance of developing
the therapeutic relationship or developing rapport with their
patients in order to proceed successfully in therapy. Dr.
Abby, Dr. Ender, Dr. Grant, Dr. Kelly and Dr. Rourke all
mentioned the importance of developing trust with their
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patients, which was accomplished by providing a safe and
stable environment, in which it was effectively conveyed the
therapist intended to become a part of the patient’s support
network. In other words, the participants indicated they
expressed to their patients that the relationship they were
developing was not transitory, and even if therapy ended and
they did not see one another for years, they would always
consider themselves to be the patient’s therapist and would be
always be available if the patient needed them. As one
participant stated, “I am there for my patients from diagnosis
to death.”
Progress
As mentioned, most participants mentioned that progress
began with first stabilizing their patients on medication.
Participants then could move on to focusing on other aspects
of therapy such as improving the daily functioning of their
patient, such as self-exploration or social relationships. In
other words, once the patient had been stabilized, they could
then move on to focus on aspects, which they qualified as
areas of QoL.
Implications
Implications from this study suggest that while most
participants indicate a desire to develop a strong rapport and
relationship with their patients, progress is dependent on
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first stabilizing the patient on medication. As all
participants are psychologists, and not psychiatrists or in
possession of a medical degree, this indicates that treatment
at this critical and initial part of treatment is immediately
dependent on the intervention of another, separate doctor,
which can involve independent referrals, new appointments and
the delay of therapy. The significance of what the
interruption to treatment could be, perhaps in terms of the
patient’s motivation or to the therapeutic relationship,
remains unmeasured. However, in considering how this may
impact the therapeutic relationship, as Dr. Perin put it, “it
sends the message, I can’t deal with you unless you’re
drugged.”
Additionally, almost all participants indicated their
patients did not tend to have insight into their disorder,
expressed some element of resistance, or needed a significant
amount of support and monitoring. So while these
characteristics were accepted attributes of the bipolar
patient for most of the participants, providing support and
facilitating insight came secondary to symptom reduction.
All participants expressed empathy for the struggle their
patients were enduring, a desire to develop the therapeutic
relationship, and revelation that their primary goal of
patient stabilization on medication is fueled by hopes of
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significant work together in the future. Bipolar disorder is a
challenging, complex disorder for both the patient and the
therapist, posing various obstacles in treatment that do not
always have a clear-cut answer or plan of action. However, as
a formal diagnosis requires both the presence of symptoms as
well as functional impairment, reason would follow that
remission or recovery would entail the resolution of both
symtomology as well functional improvement. A primary focus on
symptom reduction not only neglects a large portion of what
constitutes the disorder itself, it also ignores the
embodiment of recovery and this continues to be a dilemma in
mental health treatment, as further evidenced by the
narratives from the interviews in this study.
In the present study, while the participants faithfully
and genuinely showed concern and care for their patients, and
demonstrated the utmost professionalism in the face of one of
the most challenging of mental illnesses, the reduction of
symptoms was prioritized over patient agency in an effort to
be consistent with what is typically considered to be
responsible and in attunement with ethical guidelines. As QoL
has been defined as an individual’s perception of his or her
position in life in relation to psychological and physical
health, social relationships, goals, expectations, and
environment (WHO, 1995), it therefore can be deduced that,
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regardless of intentions, it was uncertain as to whether or
not QoL was effectively integrated into the treatment plan by
the participants in this study.
Participants who indicated they avoided labels or
diagnosis in favor of protecting their patients from the
potentially damaging effect of stigma, “worthless blanket
statements,” did not provide much in terms of offering an
alternative explanation to the patient for what they were
experiencing. For the confused bipolar patient looking for an
explanation for his or her thoughts, feelings and behavior,
clincials are often at a loss as to how to balance a fear of
stigmatization with an authentically caring encounter. As
indicated earlier in this study, QoL encompasses an
individual’s perception of his or her position in life in
relation to psychological health (Who, 1995). The patient’s
lack of understanding, perpetuated confusion, or even the
therapist’s countertransference regarding diagnosis, can
influence recovery and consequently impact QoL.
Based on the conclusion on these findings, five out of
nine participants prioritized medication. While participants
all agreed their patients tended to lack insight into their
disorder, many decided against providing a clear picture of
what BD is in favor of steering clear of blanket statements,
or overwhelming their patients with traumatic information they
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may not be ready for. Participants credited the next step in
therapy with the development of the therapeutic relationship.
In reflecting on the dilemma between addressing the immediate
crisis presentation that often accompanies BD, particularly
Bipolar I, and balancing authentic listening and engaging,
rapport may be compromised if the therapist is not fully
considering the patient’s view or reaction(s) to medication,
and then even being honest about the patient’s diagnosis.
Future studies could address the question of how
psychologists and others in the mental health community would
have a better understanding of the importance of integrating
the patient’s QoL into the treatment plan by not only focusing
on symptom reduction, but rather taking a biopsychosocial
approach that prioritizes patient agency, context, meaning
making, and lived experience. Focusing on the patient’s QoL
will incorporate an individual’s psychological, social, and
physical wellbeing, along with his or her ability to function
in the ordinary daily tasks of living. For example, this can
be accomplished by working on specific ways to reintegrate the
patient back into school or work after a hospitalization,
learning relationship skills, or how to cope with emotions.
As stated, all participants in this study showed great
care and concern for their patients, which was evident in
their ability to ethically and responsibly assist first and
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foremost in anything that posed a risk to their safety. The
goal is to find a marriage between the traditional methods of
clinical symptom reduction and the nontraditional
incorporation of QoL in order to prevent rehospitalization,
lessen the recurrence of episodes, and enhance the mental
health of the patient.
Strengths and Weaknesses of the Study
All of the participants in this study were from a small
city in southern California, which narrowed the scope of this
research. Additionally, there were a small number of
participants involved. This suggests avenues for future study
in other areas of the state and or country.
Strengths of this study were the openness and honesty of
the therapists sharing their experiences with current and past
patients. All therapists involved understood the concept of
this project, had many years of experience, and expressed a
desire to share their knowledge for the purpose of helping
further bipolar research.
Recommendations for Future Studies
Recommendations for future study include a study with a
larger sample size and, as mentioned, populations in other
areas of California and the United States.
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Another area recommended for further research is in age
of onset and how it impacts QoL. As mentioned, statistics show
that age at onset occurs at a particularly critical
developmental stage and a child experiencing symptoms of BD
may develop a sense of self characterized by who they are
during an episode and between episodes. Further research is
needed to investigate the extent of this impact. This can be a
particularly important area of interest as an integration of
QoL into the treatment plan from the beginning can possibly
set the stage for a more realistic picture of the future,
acceptance of the disorder, and a more integrative treatment
plan that incorporates the goals and expectations of the
child.
A third area suggested for further research is the impact
to the patient when treatment is interrupted by a referral to
an outside doctor, and the work is not done in tandem. For
example, is the relationship with the patient’s psychologist
impaired when the psychologist immediately refers the patient
to a psychiatrist?
Conclusion
Bipolar disorder is an acute, lifelong disorder that,
particularly with the Bipolar I diagnostic distinction, often
causes grave and debilitating consequences for its sufferers.
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Consequently, providing adequate and successful treatment for
this population is imperative.
Traditional recovery outcomes in BD have been determined
by objective measures based on the pathology of the patient,
such as recurrence of episodes, response to medication, or
degree of symptom remission on clinician-rated assessment
scales. This does not always take into full account the
patient-centered, biopsychosocial approach to BD, prioritizing
patient agency, context, meaning making, and lived experience.
In other words, the patient’s QoL in the formulation of the
treatment plan is neglected in favor of traditional and
perhaps more concrete forms of recovery. Participants showed
deep concern for the stability of their patients, a strong
desire for rapport through the development of trust and
conveyance of constancy, and an innate passion for progress.
However, the majority of participants’ treatment plans were
not tailored around the individual’s perception of his or her
position in life.
As QoL has already been shown to be significantly reduced
in bipolar patients, and elevated depression tied to
recurrence of episodes and rehospitalization, it follows that
a clinical picture of recovery could benefit by including a
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Appendix A: Recruitment Letter
Date:
To Whom It May Concern:
I am a graduate student at Antioch University in Santa Barbara
conducting research on therapist’s integration of quality of
life (QoL) into the treatment of their bipolar patients. I am
looking for licensed psychologists who have treated at least
one bipolar patient. I will travel to you or conduct the
interview over the telephone or via Skpe.
Participation in this study is strictly confidential, and
action will be employed to ensure interviewing methods and
materials are kept confidential. I will be happy to discuss
these methods with you at any time.
If you are interested in participating in this study, please
contact me at (805) 453-1866 or send an email to
CarolynnShor@gmail.com.




Antioch University, Santa Barbara
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Appendix B: Dissertation Questionnaire
Preface: I will be asking you a series of questions about your
treatment and therapeutic interaction with your bipolar
patient(s). All of these questions relate to the integration
of quality of life in the treatment plan.
7. Where did you learn to treat bipolar disorder?
8. What do you consider to be the three most important
factors in treating someone with BD?
9. What has been your experience with bipolar patients and
their understanding of their disorder?
10. What are your thoughts on the idea of “clinical”
recovery versus “functional” recovery?
11. How do you integrate the quality of life into your
treatment?
12. What have you noticed when integrating this
construct in your treatment plan?
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Appendix C: Consent Form
Project Title: Treating Bipolar Disorder: Investigation into
the Integration of Quality of Life in the Treatment Plan
Project Investigator: Carolynn Shor, M.A.
Dissertation Chair: Juliet Rohde-Brown, Ph.D.
About this consent form
Please read this form carefully. It tells you important
information about this research study. If you have any
questions about the research or about this form, please ask.
If you decide to take part in this research study, you must
sign this form to show that you want to take part. You will be
given a copy of this form.
1. You understand that this study is of a research nature.
It may offer no direct benefit to me.
2. Participation in this study is voluntary. You may refuse
to enter it or withdraw at any time without creating any
harmful consequences to myself.
a. If you withdraw your permission, you will not be
able to take back information that has already been
used.
3. The main purpose of this study is to investigate how
psychologists incorporate Quality of Life (QoL) into
their treatment of bipolar patients, as well as their
personal experiences, concerns, and assumptions.
Participation in this study will further the
understanding of the treatment of bipolar patients and
possibly enhance the ability of therapists to work more
effectively with their patients.
4. As a participant in this study, you will be asked to take
part in the following procedures:
a. Reviewing and completing this consent form.
b. Participating in an interview that will last
approximately 30 minutes.
c. Completing a brief demographic questionnaire.
d. Participation will take place in my office or over
the telephone.
5. There are no known risks, discomforts or inconveniences
associated with participation in this study.
6. The possible benefits of the procedure might be:
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a. Direct benefit to you: Discussing issues related to
QoL may increase your awareness of additional
factors involved in complete recovery.
b. Benefits to others: further the understanding of the
treatment of bipolar patients and possibly enhance
the ability of therapists to work more effectively
with their patients.
7. Data will be identified with a random number and all
personal information (name, address, phone number) will
be stored on a password protected computer file. Only the
researcher and dissertation chair will have access to
this information.
8. Information about the study was discussed with you with
Carolynn Shor.
If you have further questions you can call her at (805)
453-1866
Date:____________________ Signed:____________________
